54
Participants
Start Date
November 15, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Foralumab
"Foralumab nasal solution is a preservative-free, sterile, clear, colorless-to-slightly-yellow solution filled in an Aptar Unidose nasal atomizer device. Each Unidose device contains 0.13 mL foralumab placebo nasal solution, sufficient for administration to a single nare. Two Aptar Unidose devices will be used for a single dose (one device per nare).~Each Unidose device contains foralumab nasal solution, supplied at either 25 μg foralumab or 50 μg foralumab, sufficient for administration into a single nare."
Placebo
Foralumab placebo nasal solution is a preservative-free, sterile, clear, colorless-to-slightly-yellow solution filled in an Aptar Unidose nasal atomizer device. Each Unidose device contains 0.13 mL foralumab placebo nasal solution, sufficient for administration to a single nare. Two Aptar Unidose devices will be used for a single dose (one device per nare).
RECRUITING
Cornell Weill Medical Center, New York
RECRUITING
University of Buffalo, Buffalo
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Yale, North Haven
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
University of Massachusetts, Worcester
Tiziana Life Sciences LTD
INDUSTRY